Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2016

Patient engagement in The Metastatic Breast Cancer Project

Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA
Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2016

Hypo-fractionation of prostate cancer radiotherapy

Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada
Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2016

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi
Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )
6 May 2016

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA
Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )
6 May 2016

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016

Integrating multiple omics information in the era of precision oncology

Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA
Integrating multiple omics information in the era of precision oncology ( Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA )
5 May 2016

Breast cancer risk prediction models improved by adding multiple biological markers of risk

Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA
Breast cancer risk prediction models improved by adding multiple biological markers of risk ( Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA )
4 May 2016

Physical activity may improve prostate cancer prognosis

Dr Ying Wang - American Cancer Society, Atlanta, USA
Physical activity may improve prostate cancer prognosis ( Dr Ying Wang - American Cancer Society, Atlanta, USA )
4 May 2016